Nonaddictive, Nonsedating Pain Medication Shows Promise in Diabetic Neuropathy

TV1001sr stimulates blood vessels with sodium nitrite

Positive results have been reported from a phase 2 study of TV1001sr (TheraVasc, Inc.), an investigational sustained-release, nonaddictive, nonsedating pain medication, for the treatment of patients with pain associated with diabetic neuropathy. The treatment improved pain scores and the neuropathic pain symptom inventory.


Our most popular topics on Managedcaremag.com